Lemuplamor
N/A
Report date: 2026/03/14 20:00:17
NME
Base Information
Drug NameLemuplamor
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[18]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTMS Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCorxel Pharmaceuticals IncFuji Yakuhin Co LtdCorxel Pharmaceuticals (Shanghai) Co Ltd
Inactive CompaniesBiogen Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A